drugset / Trial / NCT06938763

Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults

NCT06938763 ↗

Phase 1 Recruiting 76 enrolled Academia Sinica, Taiwan
RandomizedSequentialDouble-blindTreatment

Summary

A Phase I, Randomized, Double-blinded, Placebo-Controlled First-in-human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of J4 Dry Powder Capsule after Oral Administration of Single and Multiple Ascending Doses to Healthy Adults

Timeline

Start
2025-02-14
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject J4 Unknown — Oral

Indications